DCF — CENTRASTATE MEDICAL CENTER
Enterprise Value: $-272.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-272.2M
Enterprise Value
$-91.1M
PV of Cash Flows
$-181.2M
PV of Terminal Value
$-291.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $317.0M | $-14.3M | -5.0% | $-27.7M | $-25.2M |
| Year 2 | $326.5M | $-11.4M | -4.0% | $-25.2M | $-20.9M |
| Year 3 | $336.3M | $-8.4M | -3.0% | $-22.6M | $-17.0M |
| Year 4 | $346.4M | $-6.9M | -2.0% | $-21.6M | $-14.7M |
| Year 5 | $356.8M | $-6.2M | -2.0% | $-21.3M | $-13.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-272.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$307.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05000000113718864
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5